Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Akela Pharma Inc. AKLPF

Healthcare Biotechnology
"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."


GREY:AKLPF - Post by User

Akela Pharma Inc. > Insider
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Consultor1on Apr 22, 2011 9:13am
413 Views
Post# 18474174

RE: RE: RE: RE: Insider

RE: RE: RE: RE: InsiderInsiders continue to buy and last half hour of the day Anon was in and moved it up to .21. Believe we may see .30 plus range in the coming weeks. Next quarter should be out middle of May, and if it continues it's strenght the SP should take a big bounce up wards.

Consultor1
GLTA
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities